Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors

MLA

Julia de Paula Dutra, et al. “Structural and Molecular Characterization of Lopinavir and Ivermectin as Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors.” EXCLI Journal : Experimental and Clinical Sciences, vol. 22, Nov. 2023, pp. 1155–72. EBSCOhost, https://doi.org/10.17179/excli2023-6427.

APA

Julia de Paula Dutra, Gustavo Scheiffer, Thales Kronenberger, Lucas Julian Cruz Gomes, Isadora Zanzarini, Kelly Karoline dos Santos, Arun K. Tonduru, Antti Poso, Fabiane Gomes de Moraes Rego, Geraldo Picheth, Glaucio Valdameri, & Vivian Rotuno Moure. (2023). Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors. EXCLI Journal : Experimental and Clinical Sciences, 22, 1155–1172. https://doi.org/10.17179/excli2023-6427

Chicago

Julia de Paula Dutra, Gustavo Scheiffer, Thales Kronenberger, Lucas Julian Cruz Gomes, Isadora Zanzarini, Kelly Karoline dos Santos, Arun K. Tonduru, et al. 2023. “Structural and Molecular Characterization of Lopinavir and Ivermectin as Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors.” EXCLI Journal : Experimental and Clinical Sciences 22 (November): 1155–72. doi:10.17179/excli2023-6427.